Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Mar 7.
Published in final edited form as: Int J Infect Dis. 2015 Oct 30;41:50–52. doi: 10.1016/j.ijid.2015.10.022

Use of string test and stool specimens to diagnose pulmonary tuberculosis

Andrew R DiNardo a,*, Andrew Hahn a, Jacinta Leyden b, Charles Stager c, Ellen Jo Baron d,e, Edward A Graviss f, Anna M Mandalakas g,h,#, Elizabeth Guy i,#
PMCID: PMC4780405  NIHMSID: NIHMS755768  PMID: 26523638

SUMMARY

Background

The Xpert MTB/RIF (MTB/RIF) test has advanced the field of tuberculosis (TB) diagnostics; however, depending on age and HIV status, 10–85% of individuals with presumed pulmonary TB (PTB) are unable to produce sputum.

Methods

The feasibility of using MTB/RIF and culture on stool and string test specimens from 13 adult patients with presumed PTB was studied.

Results

The string test was well tolerated with a median Wong Baker Faces score of 2. The string test had 100% sensitivity and specificity by MTB/RIF and 87.5% sensitivity and 100% specificity by culture. In stool, Mycobacterium tuberculosis DNA was detected in all cases of culture-confirmed PTB.

Conclusion

The string test and stool provide diagnostic specimens that warrant further investigation.

Keywords: Tuberculosis, String test, Stool, Xpert MTB/RIF

1. Introduction

Until recently, the diagnosis of pulmonary tuberculosis (PTB) has relied on sputum smear microscopy and culture. Unfortunately traditional culture requires at least 10–14 days and microscopy is highly variable with 50–80% sensitivity in PTB patients without HIV infection and 40–50% in those with HIV infection.1,2 The Xpert MTB/RIF (MTB/RIF) test is an automated nucleic acid amplification technology (NAAT) that detects Mycobacterium tuberculosis DNA and rifampicin resistance in 2 h with an overall diagnostic sensitivity of 88%.3

While MTB/RIF has improved the rapidity of TB diagnostics, limitations persist. While more sensitive than smear, MTB/RIF is less sensitive than culture, likely related to its lower limit of detection of 131 CFU/ml compared to 10–100 CFU/ml for sputum culture.4 MTB/RIF fails to detect one-third of adult and 45% of pediatric smear-negative, culture-positive cases.3,5 Further, depending on age and HIV status, 10–85% of patients with presumed TB are unable to produce sputum specimens.68 Most of these individuals undergo further invasive diagnostic studies such as bronchoscopy, which is often not available in resource-limited settings. There is a need for alternative specimen collection methods that can increase microbiologically confirmed cases.3

The benefit of using gastrointestinal specimens for the diagnosis of PTB has been known since 1898, when Meunier performed the first gastric lavages in children. While the procedure was mainly reserved for pediatric patients unable to expectorate,9 in 1937 Gullbring and Levin reviewed a large series of adults in which gastric lavage detected 94% of cavitary TB and 55% of sputum-negative PTB.10 Of interest, in “closed, benign apical fibrosis”, currently designated as latent TB infection with cavitary radiography, 32% of gastric lavages found TB bacilli.10

Frustrated by a progressive and extensive case of PTB with repeated negative sputum microscopy, in 1933 Ulmar and Ornstein performed two gastric lavages, finding TB in both. Inspired by this success, and building upon previous work by Hudson using iodized oil to slow the peristaltic activity of the bronchial tree,11 Ulmar and Ornstein demonstrated the transition of bronchial fluid into the stomach by injecting iodized poppy-seed oil into the tracheobronchial tree and performed serial roentgenograms.12 Recently, with the advent of molecular diagnostics not requiring viable organisms, there has been a resurgent interest in novel gastrointestinal sources.13,14

Vargas et al. studied the utility of the string test in HIV-infected individuals with presumed PTB. The string test was superior to induced sputum in 160 cases, diagnosing 14 culture-confirmed cases compared to eight for induced sputum (p = 0.03).8 Coupled with advances in molecular diagnostics, we sought to evaluate the feasibility of gastrointestinal samples (string test and stool14) using MTB/RIF.

2. Case report

In March 2014, a 64-year-old male presented with 2 weeks of diffuse, intermittent chest pain associated with mild dyspnea, but without cough. He had lost 10 kg in weight over the past year. He had a past medical history of hypertension and diabetes mellitus, and a history of colon cancer status post resection and chemotherapy. Colonoscopy and computed tomography (CT) examination of the chest, abdomen, and pelvis performed in Bangladesh were negative for residual cancer. He had emigrated from Bangladesh 1 year previously, was a former smoker with a 45-pack-year history, and denied alcohol or illicit drug use. A physical examination was unremarkable aside from cachexia. His hemoglobin was 10.8 g/ml and creatinine clearance was 51 ml/min; other laboratory studies were normal. He reported a negative tuberculin skin test pre-immigration. His chest radiograph showed scattered bi-apical hazy opacities and nodules. Chest CT showed mild emphysematous changes and multiple bi-apical ill-defined nodules, the largest nodule measuring 2.2 cm. He had three acid-fast bacillus (AFB) smear-negative induced sputum tests. Bronchoscopic alveolar lavage (BAL) was AFB smear-negative. As part of a feasibility diagnostic study, M. tuberculosis DNA was detected in both string test and stool. The patient was started on anti-TB therapy (ATT). The BAL fluid and string test became culture-positive 3 weeks later.

3. Methods

From August 2013 to March 2014, 13 participants were enrolled at Ben Taub General Hospital (Houston, Texas, USA) with presumed PTB; these patients had received <72 h of ATT. As per routine clinical care, liquid culture (BACTEC MGIT 960) and phenotypic drug susceptibility testing was performed on M. tuberculosis isolated from the clinical samples acquired from expectorated or induced sputum. The string test was performed in the morning, after an overnight fast.8 The string capsule was swallowed, with the trailing end taped to the cheek. Four hours later it was removed by gentle traction, placed in 2 ml of phosphate buffered saline, vortexed, and 1 ml was used for MTB/RIF testing and culture.

Stool specimens were processed by two methods that do not require centrifugation. In the sugar floatation method, 0.5 g of stool was mechanically emulsified in 10 ml 50% Sheather's solution. Then the solution was manually inverted, filtered through funnel paper, and allowed to settle by gravity for 1 h. The top supernatant (0.5 ml) was incubated in a 1:1 ratio with MTB/RIF manufacturer-supplied NaOH and isopropanol decontamination Sample Reagent for 30 min and then analyzed by MTB/RIF.15 In the magnetic bead method, 0.5 g of stool was first mixed with 1 ml of the NaOH/isopropanol Sample Reagent solution, filtered using coarse material, mixed with the magnetic MicroSense Beads (Microsens Medtech Ltd, London, UK) and washed twice in accordance with the manufacturer's instructions before being tested by MTB/RIF.

This study was performed in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the institutional review boards (IRB) of Baylor College of Medicine and Harris Health System for Ben Taub General Hospital. All participants provided IRB approved written informed consent for the collection of samples and subsequent analysis.

4. Results

Of the 13 participants with presumed PTB, eight had culture-confirmed PTB. Two subjects had non-tuberculous mycobacteria pulmonary disease and three had other etiologies for their symptoms. Two of the eight patients had induced or expecto-rated sputum smear-negative, culture-positive disease. All 13 participants had successful string tests and 10 were able to provide stool samples (see Table 1). Four participants (30%) underwent bronchoscopic lavage as requested by their clinical teams.

Table 1.

Comparison of sputum, string test, and stool by smear, culture, and MTB/RIF

Sputum smear status Sputum
culture
Sputum
Xpert
String
Xpert
String
culture
MicroSense
Bead Xpert
Sugar
Xpert
Stool
culture
Wong–Baker
Faces
Mycobacterium tuberculosis culture-positive, smear-positive
2–4+ M. tuberculosis Positive Positive Positive Positive Positive Negative 1
4+ M. tuberculosis Positive Positive Positive Positive Invalid Positive 6
1+ M. tuberculosis Positive Positive Negative Negative Positive Negative 2
3+ M. tuberculosis Positive Positive Positive Positive Invalid Positive 2
3+ M. tuberculosis Positive Positive Positive Positive Positive Positive 2
1+ M. tuberculosis Positive Positive Positive Positive Positive Positive 2
Mycobacterium tuberculosis culture-positive, smear-negative
Negative M. tuberculosis Positive Positive Positive UTP 4
Negative M. tuberculosis a Positive Positive Positive Positive Invalid Negative 0
Mycobacterium tuberculosis culture-negative
1+ M. avium Negative Negative Negative Negative Invalid Positive 1
3+ M. kansasii Negative Negative Positive Negative Negative Positive 2
Negative Negativeb UTP Negative Negative UTP 2
Negative Negativec Negative Negative Negative UTP 0
Negative Negatived Negative Negative Negative Invalid Invalid Negative 2

UTP, unable to produce.

a

Smear and culture were negative from induced sputum. Bronchoscopic lavage fluid was smear-negative, but culture-positive.

b

Final diagnosis of Streptococcus milleri aspiration related to alcohol intoxication.

c

Final diagnosis unknown/undetermined and symptoms resolved.

d

Final diagnosis of interstitial lung disease related to dermatomyositis.

The string test placement and 4-h evaluation was well tolerated. Minor discomfort occurred during string removal. The median Wong–Baker Faces pain score was 2, with a range of 0 to 6 (score range of zero meaning no pain to 10 being the worst pain). MTB/RIF on string fluid had 100% sensitivity and specificity, whereas culture of string fluid had 87.5% sensitivity and 100% specificity. The string culture and MTB/RIF assay were positive in both cases of smear-negative disease.

Seven of eight participants with PTB were able to provide stool within 72 h of ATT initiation. M. tuberculosis DNA from stool was detected in seven of seven PTB subjects, using either the sugar flotation or magnetic bead procedure. The sugar flotation PCR detected four of the seven (57%) participants, while magnetic bead concentration PCR detected six of the seven (85%) participants. Stool culture was positive in four of seven samples. Five of 10 (50%) stools processed with sugar flotation yielded invalid results compared to one of 10 (10%) by magnetic beads.

Rifampicin resistance was detected by sputum, string, and stool in one case. MTB/RIF and phenotypic drug susceptibility had 100% concordance with all specimen types.

5. Discussion

Given the limitations of current methods, the feasibility and tolerability of the string test and stool for diagnosing PTB were evaluated. The string test was found to be well tolerated and provided a satisfactory sample for diagnosing PTB when used with Xpert MTB/RIF and culture. The string test analysis with MTB/RIF had 100% concordance with sputum culture, including detecting both cases of smear-negative, culture-positive disease and the one case of rifampicin resistance. A previous study using liquid and solid media in 160 patients with HIV infection reported the string test to be superior to sputum.8

The findings in this feasibility report suggest that the diagnostic yield and utility of string test and stool should be compared to sputum, the current standard of care, in a larger diagnostic study. The string test is well-tolerated, low-risk, and simple to perform. In patients who are unable to produce sputum, these methods broaden the samples available to establish a TB diagnosis and potentially avoid more invasive procedures.

Acknowledgments

Funding sources: None.

Footnotes

All authors have seen and approved the manuscript and contributed significantly to the work. The manuscript has not been published previously nor is it being considered for publication elsewhere. Contributions: Conception and Design: AD, CS, and AMM. Protocol design: AD, EG, and EJB. Implementation: AD, AH, JL, EAG, CS, and EG. Manuscript drafting and intellectual content: AD, AH, JL, CS, EJB, EAG, AMM, and EG.

Conflict of interest: EJB is Professor Emerita at Stanford and also Technical Director at Cepheid, and provided assistance with stool processing protocols and study design, but not with data collection or data analysis. The study concept and goals were conceived with no input from Cepheid. Cepheid donated the cartridges for the project, but we did not receive any funding or other incentives. No other authors have conflicting interests.

References

  • 1.Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6:664–74. doi: 10.1016/S1473-3099(06)70602-8. [DOI] [PubMed] [Google Scholar]
  • 2.Davis JL, Cattamanchi A, Cuevas LE, Hopewell PC, Steingart KR. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:147–54. doi: 10.1016/S1473-3099(12)70232-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2013;1:CD009593. doi: 10.1002/14651858.CD009593.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229–37. doi: 10.1128/JCM.01463-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Detjen AK, DiNardo AR, Leyden J, Steingart KR, Menzies D, Schiller I, Dendukuri N, Mandalakas AM. Systematic review and meta-analysis: Xpert MTB/RIF for the diagnosis of pulmonary tuberculosis, peripheral lymph node TB and TB meningitis in children. WHO Expert Group Meeting on the Use of Xpert MTB/RIF in TB Control in Low and Middle-Income Settings.. WHO Expert Meeting; Veyrier-du-Lac. May 20-21, 2013. [Google Scholar]
  • 6.Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis. 2012;54:1388–96. doi: 10.1093/cid/cis190. [DOI] [PubMed] [Google Scholar]
  • 7.Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012;55:1088–95. doi: 10.1093/cid/cis598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vargas D, Garcia L, Gilman RH, Evans C, Ticona E, Navincopa M, et al. Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. Lancet. 2005;365:150–2. doi: 10.1016/S0140-6736(05)17705-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Levin N. On the demonstration of tubercle bacilli by means of lavage of the stomach in different forms of tuberculosis in children. Acta Pediatr. 1936;17(Suppl 1):160–9. [Google Scholar]
  • 10.Gullbring ALN. The importance of gastric lavage for the demonstration of tubercle bacilli in adults. Acta Med Scand. 1937;93(1–2) [Google Scholar]
  • 11.Hudson WA JH. Cin-Ex Camera studies of the tracheobronchial tree. Arch Surg. 1929;19:1236–44. [Google Scholar]
  • 12.Ulmar D OG. Gastric examination in pulmonary tuberculosis with negative sputum: diagnostic importance. JAMA. 1933;101:835–6. [Google Scholar]
  • 13.El Khechine A, Henry M, Raoult D, Drancourt M. Detection of Mycobacterium tuberculosis complex organisms in the stools of patients with pulmonary tuberculosis. Microbiology. 2009;155(Pt 7):2384–9. doi: 10.1099/mic.0.026484-0. [DOI] [PubMed] [Google Scholar]
  • 14.Nicol MP, Spiers K, Workman L, Isaacs W, Munro J, Black F, et al. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis. 2013;57:e18–21. doi: 10.1093/cid/cit230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cepheid [30 Sept 2014];Xpert MTB/RIF Package Insert. 2015 Available at: http://www.cepheid.com/administrator/components/com_productcatalog/library-files/3a9ca7ef6b9b88dc736e5a437f41eb3a-Xpert-MTBRIF-ENGLISH-PackageInsert-301-1404-Rev-C.pdf.

RESOURCES